-
1.
公开(公告)号:MX2012004790A
公开(公告)日:2013-02-01
申请号:MX2012004790
申请日:2010-10-21
Applicant: VERTEX PHARMA
Inventor: SHETH URVI , ROEPER STEFANIE , HURLEY DENNIS JAMES , AMBHAIKAR NARENDRA BHALCHANDRA , HUGHES ROBERT , LITTLER BENJAMIN , LEE ELAINE CHUNGMIN , NUMA MEHDI
IPC: C07D215/56 , C07D487/08
Abstract: La presente invención se relaciona con procesos para preparar formas en estado sólido de N-(4-(7-azabiciclo [2.2.1]heptan-7-il)-2-(trifluorometil)fenil)-4-oxo-5-(trifluorome til)-1,4-dihidroquinolina-3-carboxamida, entre las que se incluyen la Forma A del Compuesto 1, la Forma A-HC1 del Compuesto 1, la Forma B del Compuesto 1, y la Forma B-HC1 del compuesto 1, cualquier combinación de estas formas, las composiciones farmacéuticas de las mismas, y los métodos de tratamiento con las mismas.
-
公开(公告)号:CA2772792A1
公开(公告)日:2011-03-24
申请号:CA2772792
申请日:2010-09-17
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , BEAR BRIAN RICHARD , FANNING LEV T D , HUGHES ROBERT , LITTLER BENJAMIN
IPC: C07D487/08
Abstract: The present invention relates to a process for preparing azabicyclic compounds that are useful intermediates for synthesizing pharmaceutical compounds or salts thereof.
-
公开(公告)号:NZ598277A
公开(公告)日:2014-03-28
申请号:NZ59827710
申请日:2010-09-17
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , HUGHES ROBERT , BEAR BRIAN RICHARD , FANNING LEV T D , LITTLER BENJAMIN
IPC: C07D487/08
Abstract: 598277 The present disclosure relates to a process for preparing azabicyclic compounds that are useful intermediates for synthesizing pharmaceutical compounds or salts thereof. The process comprises contacting trans-4-aminocyclohexanol with Boc anhydride to produce a compound of formula A, contacting a compound of formula A with methanesulfonic acid to produce a compound of formula B contacting a compound of formula B with trifluoroacetic acid to produce a compound of formula C and contacting a compound of formula C with hydroxide to produce a compound of formula 7.
-
公开(公告)号:AU2010295461A1
公开(公告)日:2012-03-08
申请号:AU2010295461
申请日:2010-09-17
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , BEAR BRIAN RICHARD , FANNING LEV T D , HUGHES ROBERT , LITTLER BENJAMIN
IPC: C07D487/08
Abstract: The present invention relates to a process for preparing azabicyclic compounds that are useful intermediates for synthesizing pharmaceutical compounds or salts thereof.
-
公开(公告)号:BR112012009583A2
公开(公告)日:2015-09-29
申请号:BR112012009583
申请日:2010-10-21
Applicant: VERTEX PHARMA
Inventor: LITTLER BENJAMIN , HURLEY DENNIS JAMES , LEE ELAINE CHUNGMIN , NUMA MEHDI , AMBHAIKAR NARENDRA BHALCHANDRA , HUGHES ROBERT , ROEPER STEFANIE , SHETH URVI
IPC: C07D215/56 , C07D487/08
-
公开(公告)号:ZA201201252B
公开(公告)日:2013-05-29
申请号:ZA201201252
申请日:2012-02-20
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , BEAR BRIAN RICHARD , FANNING LEV T D , HUGHES ROBERT , LITTLER BENJAMIN
IPC: C07D20060101
-
公开(公告)号:AU2010310612A1
公开(公告)日:2012-06-14
申请号:AU2010310612
申请日:2010-10-21
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , HUGHES ROBERT , HURLEY DENNIS JAMES , LEE ELAINE CHUNGMIN , LITTLER BENJAMIN , NUMA MEHDI , ROEPER STEFANIE , SHETH URVI
IPC: C07D215/56 , C07D487/08
Abstract: The present invention relates to processes for preparing solid state forms of N-(4-(7-azabicyclo[2.2. 1]heptan-7-yl)-2-(trifluoromethyl)phenyl)-4-oxo-5-(trifluoromethyl)-1,4-dihydroquinoline-3-carboxamide, including Compound 1 Form A, Compound 1 Form A- HCl, Compound 1 Form B, and Compound 1 Form B-HCl, any combination of these forms, pharmaceutical compositions thereof, and methods of treatment therewith.
-
公开(公告)号:AU2010295461B2
公开(公告)日:2016-03-03
申请号:AU2010295461
申请日:2010-09-17
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , BEAR BRIAN RICHARD , FANNING LEV T D , HUGHES ROBERT , LITTLER BENJAMIN
IPC: C07D487/08
Abstract: The present invention relates to a process for preparing azabicyclic compounds that are useful intermediates for synthesizing pharmaceutical compounds or salts thereof.
-
公开(公告)号:ES2540810T3
公开(公告)日:2015-07-13
申请号:ES10757544
申请日:2010-09-17
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , BEAR BRIAN RICHARD , FANNING LEV T D , HUGHES ROBERT , LITTLER BENJAMIN
IPC: C07D487/08
Abstract: Un proceso para preparar el Compuesto 7.**Fórmula** o una sal farmacéuticamente aceptable del mismo, que comprende poner en contacto trans-4-aminociclohexanol con anhídrido Boc para producir un compuesto de fórmula A**Fórmula** poner en contacto un compuesto de fórmula A con cloruro de metanosulfonilo para producir un compuesto de fórmula B**Fórmula** poner en contacto un compuesto de fórmula B con ácido trifluoroacético para producir un compuesto de fórmula C**Fórmula** y poner en contacto un compuesto de fórmula C con hidróxido para producir un compuesto de fórmula 7.
-
公开(公告)号:NZ600172A
公开(公告)日:2014-07-25
申请号:NZ60017210
申请日:2010-10-21
Applicant: VERTEX PHARMA
Inventor: AMBHAIKAR NARENDRA BHALCHANDRA , HUGHES ROBERT , HURLEY DENNIS JAMES , LEE ELAINE CHUNGMIN , LITTLER BENJAMIN , NUMA MEHDI , ROEPER STEFANIE , SHETH URVI
IPC: C07D215/56 , C07D487/08
Abstract: Disclosed herein is a process for producing the hydrochloride salt of Compound 1 having solid Form A-HCl comprising: (a) reacting Compound 2 with the hydrochloride salt of Formula 3 (3-HCl) in the presence of a coupling agent, a base, and a polar aprotic solvent; wherein the coupling agent is selected from the group consisting of 2-chloro-1,3-dimethyl-2-imidazolium tetrafluoroborate, 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate (HBTU), 2-chloro-4,6-dimethoxy-1,3,5-triazine, 1-H-benzotriazolium-1-[bis(dimethyl amino)methylene]-5-chlorohexafluorophosphate (HCTU), 2-(1H-7-Azabenzotriazol-1-yl)-1,1,3,3-tetramethyl uronium hexafluorophosphate (RA TU), 1-hydroxybenzotriazole (HOBT)/ 1-(3-(dimethylamino)propyl)-3-ethyl-carbodiimide hydrochloride (EDCl), and propane phosphonic anhydride; wherein the base is selected from the group consisting of K2CO3, Et3N, N-methylmorpholine (NMM), pyridine, and diisopropylethyl amine (DIEA); and wherein the polar aprotic solvent is selected from the group consisting of ethyl acetate, isopropyl acetate, tetrahydrofuran, methylethyl ketone, N-Methyl-2-pyrrolidone, acetonitrile, N,N-dimethyl formamide, and 2- methyltetrahydrofuran; and (b) treating a mixture comprising the product of step (a) with HCl; wherein step (a) is performed at a reaction temperature that is maintained between 15°C and 70°C.
-
-
-
-
-
-
-
-
-